Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600125429Phase 4Not yet recruiting
Phase 4, randomised trial of dimdazenil in Insomnia (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Change in Flinders Fatigue Scale score from baseline to Day 14. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600125429.